The 12 closest competitors and alternatives to Tempus AI among medical - healthcare information services companies — ranked by similarity to what Tempus AI actually does, not by market-cap band.
Subscribe to see Tempus AI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tempus AI, Inc. is an American health technology company founded in 2015 in Chicago, Illinois. The company builds a practical platform to gather and analyze clinical and molecular data, empowering physicians to make data-driven patient care decisions.
Tempus AI is a medical - healthcare information services company headquartered in Chicago, United States. It is publicly listed (TEM) with a market capitalisation of $12.1B. Xcout tracks 21 named people at Tempus AI, including Ryan Fukushima (Chief Executive Officer of Data & Apps). Xcout recorded 265 job postings from Tempus AI in the last 90 days, naming tools such as Salesforce, Looker, Cursor.
15 more named people on record for Tempus AI, with roles, board committees and tenure — see the full roster →
Xcout recorded 265 job postings from Tempus AI in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it and all 24 tools — see Tempus AI's hiring signals →
5 corporate events on record, with sources — see the full timeline →
Ranked by semantic similarity — how close each company is to Tempus AI by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Healthcare & Cancer Diagnostics
Orchestra Health Technologies provides a platform combining proprietary software and care navigators to streamline the oncology diagnostic journey from biopsy to treatment decisions. The company serves cancer patients, oncologists, pathologists, and healthcare executives by coordinating pathology, molecular testing, and multi-disciplinary team workflows to accelerate precision medicine.
Healthcare Technology
Lab Angelus, Inc. builds digital infrastructure and coordination platforms that connect community pathology laboratories with molecular reference laboratories for precision oncology. Its flagship product, LabDispatch, streamlines cancer specimen logistics and testing workflows to help patients receive timely molecular profiling and targeted treatments.
Biotechnology
Nexome Genomics provides cloud-based, integrated analytics solutions that process next-generation sequencing data for healthcare institutions. The company enables hospitals, medical centers, and physician offices to generate on-demand diagnostic and prognostic reports for precision medicine.
Healthcare
Concerto HealthAI was a healthcare technology company that used artificial intelligence and real-world data to support drug development and precision medicine. It primarily served biopharmaceutical companies, helping them generate clinical evidence and identify or stratify patients, particularly in oncology.
Healthcare
Innocras is a genomic analysis and cancer big data company founded in South Korea by physician-scientists from KAIST, maintaining research and corporate presence in both the United States and Korea. The company specializes in advanced cancer diagnostics and genomic technology to support precision oncology.
Enterprise Systems (Healthcare)
Genoox provides a cloud-based genomic data platform for healthcare organizations, including clinical laboratories and healthcare providers. Its platform supports genomic data management, variant interpretation, and clinical decision-making for precision medicine.
Healthcare
Aitiologic is a precision-medicine startup based in Vienna that develops liquid biopsy platforms, including the aitios platform and aitios NIPPT. The company focuses on advanced molecular diagnostics to support personalized healthcare.
Healthtech
CancerIQ, Inc. is a healthcare technology company headquartered in Chicago, Illinois, that connects patients and providers to preventative cancer innovations and risk assessment tools.
Healthtech
Valius Health, Inc. provides comprehensive cancer diagnostic and tumor profiling services for patients and oncologists. The company analyzes tumor DNA, RNA, and proteins to identify actionable therapeutic targets and treatment options.
Biotechnology
Matrix Genetics, LLC provides CLIA-certified hereditary cancer genetic testing, pharmacogenomics, and precision medicine services powered by AI. Based in a Chicago laboratory, the company offers a subscription-based health plan for individuals to assess cancer risks, match medications, and analyze DNA insights.
Biotech
Belay Diagnostics is a medical and diagnostic laboratory based in Chicago, Illinois, that specializes in precision medicine and cerebrospinal fluid liquid biopsies for central nervous system cancers.
Biotechnology
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tempus AIand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →